Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.1%
    Check dated 2024-09-04T06:24:42.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.
    Difference
    0.0%
    Check dated 2024-08-14T00:56:51.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-08-06T23:36:56.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The website has removed the 'Last Update Posted (Estimated)' and replaced it with a definitive 'Last Update Posted' indicator.
    Difference
    0.0%
    Check dated 2024-07-30T23:30:21.000Z thumbnail image
  7. Check
    37 days ago
    Change Detected
    Summary
    A new study on Zolbetuximab (IMAB362) for treating advanced gastric and gastroesophageal junction cancer has been added, focusing on its effectiveness and safety, while a previous study assessing its antitumor activity and pharmacokinetics has been removed.
    Difference
    11%
    Check dated 2024-07-29T21:58:20.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 5 more interventions/treatments and noting that the study now has 26 locations, while the previous version v2.9.7 has been removed.
    Difference
    0.2%
    Check dated 2024-07-23T15:17:46.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.